Article

Molnupiravir Use and Severe Covid-19 Outcomes During the Omicron Surge

2022-09-29

Abstract excerpt

<title>Abstract</title> <p>Background The oral antiviral molnupiravir is moderately effective in high-risk, unvaccinated non-hospitalized patients infected with early variants of SARS-CoV-2. Data regarding the effectiveness of molnupiravir against the B.1.1.529 (omicron) variant and in vaccinated populations are limited. Methods We obtained data for all members of Clalit Health Services, 40 years of age and old...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 43931a18-9bd2-5fa4-82b7-580189f09a69
DOI: 10.21203/rs.3.rs-2115769/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Molnupiravir Use and Severe Covid-19 Outcomes During the Omicron SurgeDOI 10.21203/rs.3.rs-2115769/v1Read

Oral Nirmatrelvir and Severe Covid-19 Outcomes During the Omicron SurgeSemantic proximity Read

Real-world data concerning the efficacy of molnupiravir in patients vaccinated against COVID-19 during the Omicron surge in JapanSemantic proximity Read

Real-world experience with molnupiravir during the period of SARS-CoV-2 Omicron variant dominanceSemantic proximity Read

Real-world effectiveness of molnupiravir and nirmatrelvir/ritonavir among COVID-19 community, highly vaccinated patients with high risk for severe disease: Evidence that both antivirals reduce the risk for disease progression and deathSemantic proximity Read

Effectiveness of vaccination against SARS-CoV-2 Omicron variant infection, symptomatic disease, and hospitalisation: a systematic review and meta-analysisSemantic proximity Read

Incidence and risk factors of omicron variant SARS-CoV-2 breakthrough infection among vaccinated and boosted individualsSemantic proximity Read

Effectiveness of Molnupiravir for the Treatment of COVID-19: A Systematic Literature Review of Real-World Observational StudiesSemantic proximity Read

Effectiveness of Molnupiravir for the Treatment of COVID-19: A Systematic Literature Review of Real-World Observational StudiesSemantic proximity Read

Nirmatrelvir/ritonavir and molnuipiravir in the treatment of mild/moderate COVID-19: results of a real-life studySemantic proximity Read

Real World Effectiveness of Tixagevimab/cilgavimab (Evusheld) in the Omicron EraSemantic proximity Read

Reduced Risk of Hospitalisation Associated With Infection With SARS-CoV-2 Omicron Relative to Delta: A Danish Cohort StudySemantic proximity Read

Effectiveness of Sotrovimab in Preventing COVID-19-related Hospitalizations or Deaths Among U.S. VeteransSemantic proximity Read